Structural and procedural characteristics of international regulatory authorities

被引：0
|
作者：
Anand B. Jain
Annette Mollet
Thomas D. Szucs
机构：
[1] Novo Nordisk Healthcare AG,
来源：
Nature Reviews Drug Discovery | 2017年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：594 / 594
相关论文
共 50 条
  • [21] NEW BIOTECHNOLOGIES - CHALLENGES FOR THE REGULATORY AUTHORITIES
    JEFFCOATE, SL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 : 191 - 194
  • [22] Biosimilars and Regulatory Authorities Editorial Comment
    El Nahas, M.
    NEPHRON CLINICAL PRACTICE, 2011, 117 (01): : C7 - C7
  • [23] European regulatory authorities and pediatric labeling
    Autret, E
    PEDIATRICS, 1999, 104 (03) : 614 - 618
  • [24] Building medical regulatory authorities in Africa
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2010, 10 (04): : 222 - 222
  • [25] Regulatory authorities set scene for VTLAs
    Aviat Week Space Technol (New York), 17 (36):
  • [26] Independence of Regulatory Authorities: The Italian Case
    Codini, Ennio
    Frego Luppi, Silvia A.
    EUROPEAN PUBLIC LAW, 2014, 20 (03): : 499 - 519
  • [27] Provision of information on regulatory authorities' websites
    Vitry, A.
    Lexchin, J.
    Sasich, L.
    Dupin-Spriet, T.
    Reed, T.
    Bertele, V.
    Garattini, S.
    Toop, L.
    Hurley, E.
    INTERNAL MEDICINE JOURNAL, 2008, 38 (07) : 559 - 567
  • [28] The practice of telemedicine and challenges to the regulatory authorities
    Kekana, Mable
    Noe, Pitso
    Mkhize, Boyce
    SOUTH AFRICAN JOURNAL OF BIOETHICS AND LAW, 2010, 3 (01) : 33 - 37
  • [29] Staying on the Right Side of the Regulatory Authorities
    Bishop, Ruth
    Dzanis, David A.
    VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2021, 37 (01) : 223 - 244
  • [30] Role of regulatory authorities and safety of the pill
    Hagemann, U
    HUMAN REPRODUCTION, 1998, 13 (09) : 2660 - 2661
12345